In pilocytic astrocytomas, CDKN2A inactivation also heralds more aggressive clinical behavior [13]; its presence in astrocytomas with piloid features is now suggestive of a distinct high-grade glioma subtype [1, 17]. Here, CDKN2A is linked to central nervous system cancer.